Accessibility Menu

Sihuan Pharmaceutical Group(FRA) TEL1

Market Cap€800.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.08
-2.96%
-0.00Today

Sihuan Pharmaceutical Group Financials at a Glance

Market Cap

€800.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€0.00

P/E Ratio

21.71

Dividend

€0.00

Beta (Volatility)

0.07 (Low)

Price

€0.08

Volume

0

Open

€0.08

Previous Close

€0.08

Daily Range

€0.08 - €0.08

52-Week Range

€0.08 - €0.21

Estimated Earnings Date

N/A

TEL1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sihuan Pharmaceutical Group

Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,843

CEO

Wei Cheng Guo, MD

Website

www.sihuanpharm.com

TEL1 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

5.68%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.61%

Dividend Yield

2.70%

Payout Ratio

N/A

Stock Overview

Market Cap

€800.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

9.00B

Volume

0

Avg. Volume

36.364

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Sihuan Pharmaceutical Group Performance Analysis

Sihuan Pharmaceutical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 308,209,863-28.6%
20232023-12-31EUR 242,898,613-21.2%
20242024-12-31EUR 244,209,9790.5%
20252025-12-31EUR 322,703,94132.1%
Sihuan Pharmaceutical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR -0.03N/A
20232023-12-31EUR -0.00-97.3%
20242024-12-31EUR -0.00275.0%
20252025-12-31EUR 0.00N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€800.63MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About TEL1

What is the current price of Sihuan Pharmaceutical Group?

Sihuan Pharmaceutical Group is trading at €0.08 per share.

What is the 52-week range for Sihuan Pharmaceutical Group?

Over the past 52 weeks, Sihuan Pharmaceutical Group has traded between €0.08 and €0.21.

How much debt does Sihuan Pharmaceutical Group have?

As of the most recent reporting period, Sihuan Pharmaceutical Group reported total debt of €123.00M.

How much cash does Sihuan Pharmaceutical Group have on hand?

Sihuan Pharmaceutical Group reported €448.15M in cash and cash equivalents in its most recent financial results.

What is Sihuan Pharmaceutical Group’s dividend yield?

Sihuan Pharmaceutical Group currently has a dividend yield of 2.70%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services